PTC Therapeutics director Michael Schmertzler disposes of USD 1.82 million in common shares
PTCT•Director reports share sales
PTC Therapeutics director Michael Schmertzler reported sales of 25,000 common shares on Aug. 26-27.
PTCT•PTCT•PTCT•PTC Therapeutics director Michael Schmertzler reported sales of 25,000 common shares on Aug. 26-27.
Shares were sold at weighted average prices between USD 71.55 and USD 73.18.
His indirect stake fell to 1,336,594 shares following the transactions.
